Novozymes

NSIS.B · Nasdaq Copenhagen · DKK

kr 413.00−1.55%−kr 6.50

Close · October 1, 2026

At a glance

Revenue growth: +8.45%; 2025 vs 2024
Net income growth: +90.84%; 2025 vs 2024
Net margin: 14.0%; 2024: 8.0%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	1,116	1,119	997	1,065	1,019	1,078	981	1,020	978	854	618	597
Cost of revenue	495	485	438	521	474	483	303	473	577	405	284	276
Gross profit	622	635	559	544	545	594	679	548	401	448	333	321
Selling, general and administrative	245	245	250	230	220	212	210	196	192	168	113	103
Research and development	120	121	113	119	110	107	111	108	103	91.6	70.3	61.8
Operating income	262	273	203	199	220	276	373	246	109	197	143	159
EBIT	262	273	203	199	220	276	373	246	109	197	143	159
EBITDA	419	423	358	346	356	413	539	382	245	313	163	203
Interest expense	29.9	8.6	18.3	15.0	15.7	19.3	14.1	18.9	24.5	18.9	16.1	4.6
Pre-tax income	222	257	153	172	175	245	108	219	43.0	47.0	124	154
Income tax	49.9	57.8	29.9	33.5	37.7	58.7	21.6	63.6	12.4	13.7	30.6	29.3
Net income	172	199	123	138	137	186	86.2	156	30.6	33.3	93.6	125
Net income to common shareholders	172	199	123	138	137	186	86.2	156	30.6	33.3	93.6	125
Basic EPS	0.37	0.43	0.26	0.30	0.29	0.40	0.31	0.33	0.06	0.08	0.34	0.45
Diluted EPS	0.37	0.43	0.26	0.30	0.29	0.40	0.31	0.33	0.06	0.08	0.34	0.45
Average shares (basic)	467	463	466	467	468	465	278	468	510	416	277	277
Average shares (diluted)	467	467	466	467	468	468	278	468	510	435	278	278
Dividend per share	0.31	—	0.57	—	0.30	—	0.83	—	0.27	—	0.27	0.56